- Open Access
Sex dependent regulation of osteoblast response to implant surface properties by systemic hormones
© Olivares-Navarrete et al; licensee BioMed Central Ltd. 2010
- Received: 24 May 2010
- Accepted: 4 November 2010
- Published: 4 November 2010
Osseointegration depends on the implant surface, bone quality and the local and systemic host environment, which can differ in male and female patients. This study was undertaken in order to determine if male and female cells respond differently to titanium surfaces that have micron-scale roughness and if interactions of calciotropic hormones [1α,25(OH)2D3 and 17β-oestradiol (E2)] and microstructured surfaces on osteoblasts are sex dependent.
Osteoblasts from 6-week old Sprague-Dawley rats were cultured on tissue culture polystyrene (TCPS) or on titanium (Ti) disks with two different surface topographies, a smooth pretreated (PT) surface and a coarse grit-blasted/acid-etched (SLA) surface, and treated with 1α,25(OH)2D3, E2, or E2 conjugated to bovine serum albumin (E2-BSA).
Male and female cells responded similarly to Ti microstructure with respect to cell number and levels of osteocalcin, transforming growth factor-β1, osteoprotegerin and prostaglandin E2 in their conditioned media, exhibiting a more differentiated phenotype on SLA than on PT or TCPS. E2 and E2-BSA increased differentiation and local factor production, an effect that was microstructure dependent and found only in female osteoblasts. 1α,25(OH)2D3 increased osteoblast differentiation and local factor production in female and male cells, but the effect was more robust in male cells.
Male and female rat osteoblasts respond similarly to surface microstructure but exhibit sexual dimorphism in substrate-dependent responses to systemic hormones. Oestrogen affected only female cells while 1α,25(OH)2D3 had a greater effect on male cells. These results suggest that successful osseointegration in males and females may depend on the implant surface design and correct levels of calciotropic hormones.
- Sexual Dimorphism
- Male Cell
- Female Cell
- Tissue Culture Polystyrene
Orthopaedic diseases, such as osteoporosis, osteoarthritis and some spinal disorders, are more prevalent in women . Until recently, most of these differences were attributed to the circulating levels of oestrogen and testosterone. However, there is increasing evidence that sexual dimorphism occurs before puberty and depends on fundamental differences at the genetic level. Bone properties, including size and shape, are inherited differently in males and females . Components of the extracellular matrix (small integrin binding, N-linked glycoproteins [SIBLING]) are encoded on the X-chromosome, causing differential expression of resulting syndromes . Sexual dimorphism also exists in lineage preference of mesenchymal stem cells (MSCs) [4, 5].
An ageing population has increased demand for dental implants to replace missing teeth and orthopaedic implants to restore function. Successful osseointegration of these implants, defined as direct contact between bone and the implant surface under loading conditions [6, 7], depends in part on bone quality and the local and systemic host environment. Studies have shown lower osseointegration rates in osteopenic bone than in normal bone ; in osteoporotic animals osseointegration is 50% slower than in normal experimental animals [9, 10]. Moreover, clinical trials have shown that osteoporosis is significantly related to early implant failures in males and females  and that age is a major contributing factor .
Age certainly is an important variable, but systemic hormones also contribute to early implant failure. In oestrogen-deficient animals, osseointegration is impaired, and this represented by less bone mass, a smaller contact area between bone and the implant [13, 14] and decreased pull-out strength of implants . Similarly, postmenopausal women have had significantly more failures of maxillary implants than their premenopausal counterparts . One possibility is that there is a biphasic effect of female gonadal hormone deficiency, which may temporarily interfere in early implant-tissue integration and may be associated with a failure to upregulate a select set of bone extracellular matrix genes .
Some studies suggest that oestrogen replacement therapy may promote bone healing around titanium (Ti) implants in osteoporotic bone [17, 18]. However, other studies do not show improved implant success rates . This raises the possibility that the design of the implant may also be a contributing factor. Female osteoblasts are sensitive to differences in surface morphology and their responses to oestrogen vary with the surface properties . Oestrogen is also necessary for bone strength in males  and male osteoblasts are sensitive to differences in the surface properties of Ti and Ti alloy implants [21–23], but whether oestrogen regulates the response of male osteoblasts to orthopaedic implant materials is not known.
The vitamin D metabolite 1,25-dihydroxyvitamin D3 [1α,25(OH)2D3] is another important factor regulating osteoblast differentiation and bone formation. The prevalence of vitamin D deficiency is relatively higher in certain populations, such as the elderly , pregnant women in the northern USA  or people with limited sun exposure . Recent reports indicate that fracture healing is reduced in vitamin D deficient women , suggesting that 1α,25(OH)2D3 may also modulate osteoblasts in a sex specific manner.
Successful osseointegration of an implant depends on its surface properties. In vivo, osteoblasts proliferate and differentiate in areas of bone conditioned by osteoclasts, leaving a micron-scale roughness . Microstructured Ti and Ti-6Al-4V surfaces, with a roughness similar to that found in the resorption lacunae left by osteoclasts , result in higher bone-to-implant contact and stronger mechanical integration in vivo than smooth surfaces, resulting in better osseointegration [30–33]. This result is supported by in vitro findings showing that microstructured surfaces enhance osteoblast differentiation, matrix deposition and the production of osteogenic growth factors [21–23], which regulate the cells via autocrine and paracrine pathways [34–36]. Osteoblast response to exogenous regulators, including systemic osteotropic hormones, is also sensitive to surface properties. The effects of 1α,25(OH)2D3 on human osteoblast-like MG63 cells, normal human osteoblasts, fetal rat calvarial cells and mouse osteocyte-like cells are enhanced on rougher surfaces [37, 38].
The aim of the present study was to determine if sexual dimorphism in osteoblasts involves a differential response to implant surface microstructure and if the interactions between the response to surface microstructure and the calciotropic hormones 1α,25(OH)2D3 and 17β-oestradiol are sex-dependent. The study was performed using primary osteoblasts isolated from adult male and female rats. However, it does not address the question of whether sexual dimorphism at the cell level affects the long-term success of orthopaedic implants in vivo.
We used an in vitro model to determine whether male and female osteoblasts exhibit differential responses to Ti surface microstructure and if there are substrate dependent differences in response to systemic hormones. Primary rat osteoblasts were cultured to confluence on Ti disks with three different surface morphologies. At confluence, they were treated for 24 hours with oestrogen (17β-oestradiol) or with 1α, 25(OH)2D3. Outcome measures included cell number, alkaline phosphatase specific activity, osteocalcin production and the production of growth factors. In each experiment there were six independent cultures per variable (male, female, surface, hormone concentration) and all experiments were repeated to ensure the validity of the findings.
Ti disks with a 15 mm diameter were prepared from Ti sheets as described previously . Pretreatment disks (PT) were cleaned by washing in acetone and processing them through a 2% ammonium fluoride/2% hydrofluoric acid/10% nitric acid solution at 55°C for 30 s. In order to produce disks with a mixed micron scale and submicron scale topography (coarse grit-blasted/acid-etched, SLA), PT disks were coarse grit-blasted with 0.25-0.50 mm corundum until the surface reached a uniform gray tone, followed by acid etching. The surface parameters for each of the surfaces have been described in detail . The PT surface is comparatively smooth with an average peak to valley roughness (Ra) of 40 nm. The SLA surface is characterized by 30 to 100 μm craters overlaid with 1-3 μm pits, resulting in an Ra of 3.2 μm. Control cultures were grown on standard tissue culture polystyrene (TCPS).
Osteoblasts were isolated from frontal and parietal (calvaria) bones of 6-week-old male (n = 8) and female (n = 8) Sprague-Dawley rats using an explant isolation technique . Periosteum and soft tissues were removed from the bones. Pieces with a 1-2 mm diameter were washed three times in Hank's balanced salt solution (HBSS) containing penicillin-streptomycin, and digested for 15 minutes at 37°C with 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA; Invitrogen, CA, USA). The digestion was discarded in order to avoid fibroblast contamination. The bone chips were placed in a 100 × 20 Petri dish (BD, NJ, USA) and cultured in Dulbecco's modified Eagle medium (DMEM; cellgro®, Mediatech, Inc, VA, USA) containing 1% penicillin-streptomycin (Invitrogen) and 10% fetal bovine serum (Hyclone, UT, USA). At confluence, the cells were subpassaged and cultured as above. Confluent third passage cultures were used for the experiments described below. In order to ensure that these cells retained osteoblastic responses to 1α,25(OH)2D3 at this passage, we examined the dose-dependent effects of the seco-steroid on cell number, alkaline phosphatase specific activity and osteocalcin production. Confluent cultures were treated with 10-9M or 10-8M 1α,25(OH)2D3 for 24 hours.
Validated rat osteoblasts were plated at 20,000 cells/cm2 on TCPS, PT and SLA substrates. Media were exchanged at 24 hours and then every 48 hours until cells reached confluence on TCPS. At confluence, media were replaced with experimental media containing vehicle or 1α,25(OH)2D3 (10-9 and 10-8M) (Biomol Research Laboratories, PA, USA) or 10-9M 17β-oestradiol (E2) or E2 conjugated to bovine serum albumin (E2-BSA, Sigma-Aldrich Co, MO, USA), which prevents diffusion of E2 across the plasma membrane, thereby activating membrane-mediated E2-signalling .
When the osteoblast cultures achieved confluence on TCPS, all the cultures were treated for 24 hours with media containing either vehicle or the appropriate hormone concentration. The cell number was determined at harvest for all the cultures. Cells were released by two sequential 10 minute incubations in 0.25% trypsin at 37°C in order to ensure that all cells were removed from rough Ti surfaces and counted (Z1 cell and particle counter, Beckman Coulter, CA, USA). In order to measure the cellular alkaline phosphatase specific activity [orthophosphoric monoester phosphohydrolase, alkaline; E.C. 18.104.22.168], cells were lysed by freeze-thawing in Triton-X100. Enzyme activity in the lysates was assayed by measuring the release of p-nitrophenol from p-nitrophenylphosphate at pH 10.2 and results were normalized to the protein content of the cell lysates. Osteocalcin in the conditioned media was measured using a commercially available radioimmunoassay kit (Human Osteocalcin RIA Kit, Biomedical Technologies, MA, USA) and normalized by cell number. The conditioned media were also assayed for growth factors and cytokines. The prostaglandin E2 (PGE2) was assessed using a commercially available competitive binding radioimmunoassay kit (Prostaglandin E2 RIA kit, Perkin Elmer, MA, USA). Active transforming growth factor (TGF)-β1 was measured prior to acidification of the conditioned media, using an enzyme-linked immunoassay (ELISA) kit specifically for human TGF-β1 (TGF-β1 DuoSet, R&D Systems, MN, USA). The total TGF-β1 was measured after acidifying the media and the latent TGF-β1 was defined as total TGF-β1 minus active TGF-β1. The osteoprotegerin (OPG) levels were measured using an ELISA kit (Osteoprotegerin DuoSet, R&D Systems).
The experimental design was controlled as far as possible in order to ensure that any sex differences were not due to an artifact. Male or female cells were collected from a minimum of eight rats each for each experiment. Rats of the same sex were euthanized on the same day and cells were harvested together. Male and female cells were collected one week apart. In order to eliminate the possibility that differences between male and female cell behaviour were artifacts of different tissue culture conditions, we strictly controlled the culture conditions and used the same processes to sterilize the Ti surfaces, cell isolation procedures, cell seeding densities and culture media. Moreover, the biochemical analyses were performed at the same time.
Each variable was tested in six independent cultures for each experiment so that we could statistically compare the responses of the male and female cells to each surface and to each hormone treatment on a specific surface in a single experiment. All the experiments were repeated in order to ensure the validity of the results. The data presented are from representative experiments. The data were first analysed by analysis of variance; when statistical differences were detected, Student's t-test for multiple comparisons using Bonferroni's method was used. We compared the responses on each Ti surface to the response on TCPS for each hormone treatment. In addition, we compared the response to each dose of hormone to the response to control media for each of the surfaces.
Cell response to Ti substrates
Osteoblast response to 17β-oestradiol
Sexual dimorphism was evident in the response of cells to oestrogen, with responses to the hormone being evident only in the cells from female rats (Figures 2 and 4). Moreover, the response of the female cells was substrate dependent. E2 caused a decrease in the number of cells in females on TCPS and PT but had no effect on cell numbers on the rough SLA surface (Figure 2A). In contrast, E2 had no effect on male osteoblast numbers on any substrate (Figure 2B). E2-BSA did not regulate cell numbers in either female or male cultures. Both forms of the hormone stimulated alkaline phosphatase in female osteoblasts but only in cultures grown on SLA (Figure 2C). Neither form of oestrogen affected the enzyme activity in male cells (Figure 2D). Female cells responded to E2 and E2-BSA with an increase in osteocalcin on all surfaces but the percent increase was greatest in cells grown on SLA (Figure 2E). Neither E2 nor E2-BSA affected osteocalcin in the male cultures (Figure 2F). E2 and E2-BSA increased PGE2 (Figure 4A) and latent TGF-β1 (Figure 4C) in the media of female cells grown on all substrates. Both forms of oestrogen increased the levels of active TGF-β1 (data not shown). Neither E2 nor E2-BSA affected the levels of PGE2 (Figure 4B) or of latent (Figure 4D) or active (data not shown) TGF-β1 in the media of male cells.
Osteoblast response to 1α,25(OH)2D3
Percent increase in response over control in male and female osteoblasts treated with 10-8M 1α,25(OH)2D3.
% Increase treatment versus control
Despite the large amount of literature on osteoblasts, there has been little assessment of whether these bone forming cells exhibit specific differences related to the sex of the animals from which they were derived. This study examined whether osteoblasts isolated from male and female rats exhibit sexual dimorphism when grown under standard cell culture conditions, as well as when grown on substrates used as implants in clinical practice. In addition, the study addressed the question of whether or not osteoblasts are sensitive to modifications in substrate microarchitecture and if they respond to osteotropic hormones in a sex-specific manner. This study shows that, under control conditions whether on TCPS or smooth or microstructured Ti, there are no apparent differences between cells taken from male or female donors. However, osteoblasts exhibit differences in their responses to oestrogen and in the robustness of their responses to 1α,25(OH)2D3 that are sex-dependent.
The present study is limited because it was conducted in vitro and used rat cells. Thus, the data cannot be correlated directly to human cells or to in vivo responses in humans. Here, all of the rats were of the same strain while, in contrast, the human population is outbred and, therefore, inter-human variability may be greater than the differences between the sexes. The goal of this study was to compare the response of male and female osteoblasts grown on implant surfaces. In our population, we have a mixture of osteoprogenitor cells and immature osteoblasts cultured from explants of frontal and parietal bones. Cells with a similar phenotype will migrate to the implant surface in vivo, allowing us to mimic the conditions crucial to osseointegration. In order to further this system, we cultured cells only in DMEM and serum and did not include any other factors traditionally used - such as dexamethasone, β-glycerophosphate or ascorbic acid. In order to minimize the potential differences due to cell numbers from individual bone samples, cells were isolated from bones in the same location of the skull, grown in the same media, seeded at the same density and treated at confluence. Thus, in this study the baseline differences between males and females are underscored. We used sexually mature rats for these experiments, so differences in exposure to sex steroids in vivo may have affected the subpopulations of osteoblasts isolated from the donor bone.
Even with these limitations, however, the results indicate that there are physiological differences in male and female osteoblasts and sexual dimorphism in the response to bone regulating hormones. This difference is more pronounced when cells are cultured on substrates other than tissue culture polystyrene. Currently, most preclinical studies of therapeutic interventions are performed in only male or only female animal models. Further investigations on sex specific differences should be performed in order to improve our understanding of cellular responses to biomaterials.
Both female and male cells exhibited a more mature phenotype when grown on SLA than when grown on TCPS or PT. This was indicated by the higher levels of osteocalcin and OPG in their conditioned media. Although we had previously shown that male cells and female cells would exhibit a more differentiated phenotype when grown on SLA in comparison to PT , we had not directly compared cells from the same species cultured under near identical conditions. The present results remove this ambiguity.
In contrast, the responses of cells cultured on the microstructured surfaces to 1α,25(OH)2D3 and E2 were sex-specific. Male cells were more sensitive to 1α,25(OH)2D3 than female cells, responding at lower concentrations. Moreover, the response of the male cells to the higher concentration of 1α,25(OH)2D3 was more robust. In addition, only the female osteoblasts exhibited responses to E2 or E2-BSA. This confirms our previous results, which showed that osteoblasts from human females exhibit surface-dependent responses to 17β-oestradiol , but we had not determined if male osteoblasts would also exhibit a response to E2 or E2-BSA. Our studies assessing the effects of E2 and E2-BSA on human articular chondrocytes and rat growth plate chondrocytes demonstrated that male cells lacked a response to 17β-oestradiol and exhibited more robust responses to 1α,25(OH)2D3 than female chondrocytes , suggesting that these are reflective of general properties of cartilage and bone cells. Another possibility is that the male and female rat osteoblasts were at different states of maturation, since response to these systemic regulators varies with the state of the cell within the osteoblast lineage .
The mechanisms that mediate these differences are not clear. One possibility is that there are differences in vitamin D receptor (VDR) and oestrogen receptor (ER) expression in female and male cells . Alternatively, components of the signalling pathways involved may play a role. Both 1α,25(OH)2D3 and 17β-oestradiol act via classical steroid hormone receptors and via membrane-dependent signalling pathways. We did not specifically assess whether there were differences in the membrane signalling by 1α,25(OH)2D3, but our finding that E2-BSA, which cannot enter the cell due to its size , had no effect on male osteoblasts indicates that this mechanism of oestrogen action is not operative in cells from male donors. Moreover, E2 acted only on female osteoblasts in order to reduce cell number, suggesting that even the traditional ER response was not operational in the male cells. Male rat osteoblasts possess traditional ERs , further supporting the hypothesis that the sex-specific effects noted in the present study were mediated by signalling pathways not functional in male cells.
The results suggest that the level of osteotropic hormones such as 1α,25(OH)2D3 and 17β-oestradiol is important to the regulation of osteoblasts during implant osseointegration. In cases where the hormone level is reduced, such as in postmenopausal females and in vitamin D deficiency , the success of the implant may be reduced. In the last decade, an oestrogen effect on the male skeleton was established, although not as extensively as in females. During ageing female bone loss is due to an increased rate of bone resorption, whereas male bone loss is the result of less bone formation , indicating that different mechanisms are involved. There is also a sex-related difference in osteocyte lacunar density in human vertebral cancellous bone . Sexual dimorphism may be attributed to differences in ER isoform expression  or in the number of receptors . Males with deficiency of ERs or aromatase had defects in skeletal phenotypes , indicating that oestrogen is an important regulator for male cells. Alternatively, the higher aromatase activity present in male cells  may convert oestrogen to testosterone, thereby reducing the effective concentration of the hormone in the male cells. Whether these mechanisms accounted for the lack of a response to oestrogen noted in the present study is not known.
The results of this study revealed the physiological difference in male and female osteoblasts and sexual dimorphism in the response to bone regulating hormones, a difference that is more pronounced when cells are cultured on substrates other than tissue culture polystyrene. Currently, most preclinical studies of therapeutic interventions are performed in only male or only female animal models. Further investigations on sex-specific differences should be performed in order to improve our understanding of cellular responses to biomaterials.
We thank Dr Marco Wieland and the Institut Straumann AG (Basel, Switzerland) for their gift of Ti disks. This research was supported by US PHS Grant AR052102 and the ITI Foundation (Basel, Switzerland).
- Tosi LL, Boyan BD, Boskey AL: Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am 2005, 87: 1631–1647. 10.2106/JBJS.E.00218PubMedView ArticleGoogle Scholar
- D'Amelio P, Rossi P, Isaia G, Lollino N, Castoldi F, Girardo M, Dettoni F, Sattin F, Delise M, Bignardi C: Bone mineral density and singh index predict bone mechanical properties of human femur. Connect Tissue Res 2008, 49: 99–104. 10.1080/03008200801913940PubMedView ArticleGoogle Scholar
- Bellahcene A, Castronovo V, Ogbureke KU, Fisher LW, Fedarko NS: Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer. Nat Rev Cancer 2008, 8: 212–226. 10.1038/nrc2345PubMed CentralPubMedView ArticleGoogle Scholar
- Matsumoto T, Kubo S, Meszaros LB, Corsi KA, Cooper GM, Li G, Usas A, Osawa A, Fu FH, Huard J: The influence of sex on the chondrogenic potential of muscle-derived stem cells: implications for cartilage regeneration and repair. Arthritis Rheum 2008, 58: 3809–3819. 10.1002/art.24125PubMedView ArticleGoogle Scholar
- Corsi KA, Pollett JB, Phillippi JA, Usas A, Li G, Huard J: Osteogenic potential of postnatal skeletal muscle-derived stem cells is influenced by donor sex. J Bone Mineral Res 2007, 22: 1592–1602. 10.1359/jbmr.070702View ArticleGoogle Scholar
- Branemark PI, Hansson BO, Adell R, Breine U, Lindstrom J, Hallen O, Ohman A: Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl 1977, 16: 1–132.PubMedGoogle Scholar
- Branemark P-I, Zarb GA, Albrektsson T: Tissue-integrated Prostheses: Osseointegration in Clinical Dentistry. Chicago/London: Quintessence Publishing; 1985.Google Scholar
- Tsolaki IN, Madianos PN, Vrotsos JA: Outcomes of dental implants in osteoporotic patients. A literature review. J Prosthodont 2009, 18: 309–323. 10.1111/j.1532-849X.2008.00433.xPubMedView ArticleGoogle Scholar
- Ozawa S, Ogawa T, Iida K, Sukotjo C, Hasegawa H, Nishimura RD, Nishimura I: Ovariectomy hinders the early stage of bone-implant integration: histomorphometric, biomechanical, and molecular analyses. Bone 2002, 30: 137–143. 10.1016/S8756-3282(01)00646-9PubMedView ArticleGoogle Scholar
- Okamura A, Ayukawa Y, Iyama S, Koyano K: Effect of the difference of bone turnover on peri-titanium implant osteogenesis in ovariectomized rats. J Biomed Mater Res A 2004, 70: 497–505. 10.1002/jbm.a.30110PubMedView ArticleGoogle Scholar
- Alsaadi G, Quirynen M, Komarek A, van Steenberghe D: Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 2007, 34: 610–617. 10.1111/j.1600-051X.2007.01077.xPubMedView ArticleGoogle Scholar
- Moy PK, Medina D, Shetty V, Aghaloo TL: Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 2005, 20: 569–577.PubMedGoogle Scholar
- Pan J, Shirota T, Ohno K, Michi K: Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite-coated implants in the tibia of mature rats. J Oral Maxillofac Surg 2000, 58: 877–882. 10.1053/joms.2000.8212PubMedView ArticleGoogle Scholar
- Yamazaki M, Shirota T, Tokugawa Y, Motohashi M, Ohno K, Michi K, Yamaguchi A: Bone reactions to titanium screw implants in ovariectomized animals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 87: 411–418. 10.1016/S1079-2104(99)70239-8PubMedView ArticleGoogle Scholar
- Martin RB, Paul HA, Bargar WL, Dannucci GA, Sharkey NA: Effects of estrogen deficiency on the growth of tissue into porous titanium implants. J Bone Joint Surg Am 1988, 70: 540–547.PubMedGoogle Scholar
- August M, Chung K, Chang Y, Glowacki J: Influence of estrogen status on endosseous implant osseointegration. J Oral Maxillofac Surg 2001, 59: 1285–1289. discussion 1290–1281 10.1053/joms.2001.27515PubMedView ArticleGoogle Scholar
- Narai S, Nagahata S: Effects of alendronate on the removal torque of implants in rats with induced osteoporosis. Int J Oral Maxillofac Implants 2003, 18: 218–223.PubMedGoogle Scholar
- Qi MC, Zhou XQ, Hu J, Du ZJ, Yang JH, Liu M, Li XM: Oestrogen replacement therapy promotes bone healing around dental implants in osteoporotic rats. Int J Oral Maxillofac Surg 2004, 33: 279–285. 10.1006/ijom.2002.0398PubMedView ArticleGoogle Scholar
- Lohmann CH, Tandy EM, Sylvia VL, Hell-Vocke AK, Cochran DL, Dean DD, Boyan BD, Schwartz Z: Response of normal female human osteoblasts (NHOst) to 17beta-estradiol is modulated by implant surface morphology. J Biomed Mater Res 2002, 62: 204–213. 10.1002/jbm.10290PubMedView ArticleGoogle Scholar
- Lapauw BM, Taes Y, Bogaert V, Vanbillemont G, Goemaere S, Zmierczak HG, De Bacquer D, Kaufman JM: Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings. J Bone Miner Res 2009, 24: 1075–1085. 10.1359/jbmr.081260PubMedView ArticleGoogle Scholar
- Brunette DM, Ratkay J, Chehroudi B: Behaviour of Osteoblasts on Micromachined Surfaces. Toronto: University of Toronto Press; 1991.Google Scholar
- Martin JY, Schwartz Z, Hummert TW, Schraub DM, Simpson J, Lankford J Jr, Dean DD, Cochran DL, Boyan BD: Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J Biomed Mater Res 1995, 29: 389–401. 10.1002/jbm.820290314PubMedView ArticleGoogle Scholar
- Deligianni DD, Katsala N, Ladas S, Sotiropoulou D, Amedee J, Missirlis YF: Effect of surface roughness of the titanium alloy Ti-6Al-4V on human bone marrow cell response and on protein adsorption. Biomaterials 2001, 22: 1241–1251. 10.1016/S0142-9612(00)00274-XPubMedView ArticleGoogle Scholar
- Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM: High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr 2007, 137: 447–452.PubMed CentralPubMedGoogle Scholar
- Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P: Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006, 84: 616–622. quiz 671–672PubMedGoogle Scholar
- Taha W, Chin D, Silverberg AI, Lashiker L, Khateeb N, Anhalt H: Reduced spinal bone mineral density in adolescents of an ultra-orthodox Jewish community in Brooklyn. Pediatrics 2001, 107: E79. 10.1542/peds.107.5.e79PubMedView ArticleGoogle Scholar
- LeBoff MS, Hawkes WG, Glowacki J, Yu-Yahiro J, Hurwitz S, Magaziner J: Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int 2008, 19: 1283–1290. 10.1007/s00198-008-0582-6PubMed CentralPubMedView ArticleGoogle Scholar
- Boyan BD, Schwartz Z, Lohmann CH, Sylvia VL, Cochran DL, Dean DD, Puzas JE: Pretreatment of bone with osteoclasts affects phenotypic expression of osteoblast-like cells. J Orthop Res 2003, 21: 638–647. 10.1016/S0736-0266(02)00261-9PubMedView ArticleGoogle Scholar
- Zinger O, Zhao G, Schwartz Z, Simpson J, Wieland M, Landolt D, Boyan B: Differential regulation of osteoblasts by substrate microstructural features. Biomaterials 2005, 26: 1837–1847. 10.1016/j.biomaterials.2004.06.035PubMedView ArticleGoogle Scholar
- Geckeler K, Wacker R, Martini F, Hack A, Aicher W: Enhanced biocompatibility for SAOS-2 osteosarcoma cells by surface coating with hydrophobic epoxy resins. Cell Physiol Biochem 2003, 13: 155–164. 10.1159/000071866PubMedView ArticleGoogle Scholar
- Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H: Influence of surface characteristics on bone integration of titanium implants. A histomorphometric study in miniature pigs. J Biomed Mater Res 1991, 25: 889–902. 10.1002/jbm.820250708PubMedView ArticleGoogle Scholar
- Wennerberg A, Hallgren C, Johansson C, Danelli S: A histomorphometric evaluation of screw-shaped implants each prepared with two surface roughnesses. Clin Oral Implants Res 1998, 9: 11–19. 10.1034/j.1600-0501.1998.090102.xPubMedView ArticleGoogle Scholar
- Schwartz Z, Raz P, Zhao G, Barak Y, Tauber M, Yao H, Boyan BD: Effect of micrometer-scale roughness of the surface of Ti6Al4V pedicle screws in vitro and in vivo . J Bone Joint Surg Am 2008, 90: 2485–2498. 10.2106/JBJS.G.00499PubMed CentralPubMedView ArticleGoogle Scholar
- Schwartz Z, Olivares-Navarrete R, Wieland M, Cochran DL, Boyan BD: Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces. Biomaterials 2009, 30: 3390–3396. 10.1016/j.biomaterials.2009.03.047PubMed CentralPubMedView ArticleGoogle Scholar
- Boyan BD, Lohmann CH, Sisk M, Liu Y, Sylvia VL, Cochran DL, Dean DD, Schwartz Z: Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness. J Biomed Mater Res 2001, 55: 350–359. 10.1002/1097-4636(20010605)55:3<350::AID-JBM1023>3.0.CO;2-MPubMedView ArticleGoogle Scholar
- Bessho K, Carnes DL, Cavin R, Chen HY, Ong JL: BMP stimulation of bone response adjacent to titanium implants in vivo . Clin Oral Implants Res 1999, 10: 212–218. 10.1034/j.1600-0501.1999.100304.xPubMedView ArticleGoogle Scholar
- Boyan BD, Batzer R, Kieswetter K, Liu Y, Cochran DL, Szmuckler-Moncler S, Dean DD, Schwartz Z: Titanium surface roughness alters responsiveness of MG63 osteoblast-like cells to 1 alpha,25-(OH)2D3. J Biomed Mater Res 1998, 39: 77–85. 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-LPubMedView ArticleGoogle Scholar
- Lohmann CH, Bonewald LF, Sisk MA, Sylvia VL, Cochran DL, Dean DD, Boyan BD, Schwartz Z: Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3. J Bone Miner Res 2000, 15: 1169–1180. 10.1359/jbmr.2000.15.6.1169PubMedView ArticleGoogle Scholar
- Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J: Enhancing surface free energy and hydrophilicity through chemical modification of microstructured titanium implant surfaces. J Biomed Mater Res A 2006, 76: 323–334.PubMedView ArticleGoogle Scholar
- Bellows CG, Aubin JE, Heersche JN, Antosz ME: Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 1986, 38: 143–154. 10.1007/BF02556874PubMedView ArticleGoogle Scholar
- Zheng J, Ali A, Ramirez VD: Steroids conjugated to bovine serum albumin as tools to demonstrate specific steroid neuronal membrane binding sites. J Psychiatry Neurosci 1996, 21: 187–197.PubMed CentralPubMedGoogle Scholar
- Stein GS, Lian JB, Owen TA: Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 1990, 4: 3111–3123.PubMedGoogle Scholar
- Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G: Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998, 23: 187–196. 10.1016/S8756-3282(98)00092-1PubMedView ArticleGoogle Scholar
- Raisz LG, Fall PM: Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 1990, 126: 1654–1659. 10.1210/endo-126-3-1654PubMedView ArticleGoogle Scholar
- Kinney RC, Schwartz Z, Week K, Lotz MK, Boyan BD: Human articular chondrocytes exhibit sexual dimorphism in their responses to 17beta-estradiol. Osteoarthritis Cartilage 2005, 13: 330–337. 10.1016/j.joca.2004.12.003PubMedView ArticleGoogle Scholar
- Nasatzky E, Schwartz Z, Soskolne WA, Brooks BP, Dean DD, Boyan BD, Ornoy A: Evidence for receptors specific for 17 beta-estradiol and testosterone in chondrocyte cultures. Connect Tissue Res 1994, 30: 277–294. 10.3109/03008209409015043PubMedView ArticleGoogle Scholar
- Gasperino J: Androgenic regulation of bone mass in women. A review. Clin Orthop Relat Res 1995, 278–286.Google Scholar
- Vashishth D, Gibson GJ, Fyhrie DP: Sexual dimorphism and age dependence of osteocyte lacunar density for human vertebral cancellous bone. Anat Rec A Discov Mol Cell Evol Biol 2005, 282: 157–162.PubMedView ArticleGoogle Scholar
- Gonzalez-Arenas A, Neri-Gomez T, Guerra-Araiza C, Camacho-Arroyo I: Sexual dimorphism in the content of progesterone and estrogen receptors and their cofactors in the lung of adult rats. Steroids 2004, 69: 351–356. 10.1016/j.steroids.2004.03.004PubMedView ArticleGoogle Scholar
- Frank GR: The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton. Acta Paediatr 1995, 84: 627–630. 10.1111/j.1651-2227.1995.tb13714.xPubMedView ArticleGoogle Scholar
- Vandenput L, Ohlsson C: Estrogens as regulators of bone health in men. Nat Rev Endocrinol 2009, 5: 437–443. 10.1038/nrendo.2009.112PubMedView ArticleGoogle Scholar